DAXOR CORP cotiza a 10.30 USD y tiene una capitalización bursátil de $60M. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
Daxor Corporation engages in medical instrumentation and biotechnology operations. It develops the BVA-100 Blood Volume Analyzer, an instrument that measures human blood volume, in conjunction with Volumex, a single-use radiopharmaceutical diagnostic injection and collection kit. The company was formerly known as Idant…
| Periodo | 2019-08 | 2019-08 | 2007-11 | 2007-08 |
|---|---|---|---|---|
| Real | $0.06 | $0.06 | $0.43 | $0.51 |
| Estimado | $0.02 | $0.02 | $0.10 | $0.01 |
| Sorpresa | +200.0% | +200.0% | +330.0% | +5000.0% |
| Métrica | DXR | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | 54.9% | 57.0% | -2.1% |
| Operating Margin | -400.1% | -38.6% | -361.4% |
| Net Margin | -496.8% | -33.6% | -463.3% |
| FCF Margin | -458.5% | -13.9% | -444.7% |
| ROE | -19.8% | -40.4% | +20.6% |
| ROA | -8.4% | -32.0% | +23.6% |
| Current Ratio | 1.66 | 2.84 | -1.18 |
| Debt / Equity | — | 0.28 | — |